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Background: Osmotic demyelination syndrome (ODS) primarily occurs after rapid correction of severe
hyponatremia. There are no proven effective therapies for ODS, but we describe the first case showing the
successful treatment of central pontine myelinolysis (CPM) by plasma exchange, which occurred after rapid
development of hypernatremia from intravenous sodium bicarbonate therapy.
Case presentation: A 40-year-old woman presented with general weakness, hypokalemia, and metabolic acidosis.
The patient was treated with oral and intravenous potassium chloride, along with intravenous sodium bicarbonate.
Although her bicarbonate deficit was 365 mEq, we treated her with an overdose of intravenous sodium bicarbonate,
480 mEq for 24 hours, due to the severity of her acidemia and her altered mental status. The next day, she developed
hypernatremia with serum sodium levels rising from 142.8 mEq/L to 172.8 mEq/L. Six days after developing hypernatremia,
she exhibited tetraparesis, drooling, difficulty swallowing, and dysarthria, and a brain MRI revealed high signal intensity in
the central pons with sparing of the peripheral portion, suggesting CPM. We diagnosed her with CPM associated with the
rapid development of hypernatremia after intravenous sodium bicarbonate therapy and treated her with plasma exchange.
After two consecutive plasma exchange sessions, her neurologic symptoms were markedly improved except for mild
diplopia. After the plasma exchange sessions, we examined the patient to determine the reason for her symptoms upon
presentation to the hospital. She had normal anion gap metabolic acidosis, low blood bicarbonate levels, a urine pH of 6.5,
and a calyceal stone in her left kidney. We performed a sodium bicarbonate loading test and diagnosed distal renal tubular
acidosis (RTA). We also found that she had Sjögren’s syndrome after a positive screen for anti-Lo, anti-Ra, and after the
results of Schirmer’s test and a lower lip biopsy. She was discharged and treated as an outpatient with oral sodium
bicarbonate and potassium chloride.
Conclusion: This case indicates that serum sodium concentrations should be carefully monitored in patients with distal
RTA receiving intravenous sodium bicarbonate therapy. We should keep in mind that acute hypernatremia and CPM can
be associated with intravenous sodium bicarbonate therapy, and that CPM due to acute hypernatremia may be effectively
treated with plasma exchange.
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Osmotic demyelination syndrome (ODS), which is also
known as central pontine myelinolysis (CPM) or extra-
pontine myelinolysis, primarily occurs after the rapid
correction of severe hyponatremia. The clinical manifes-
tations of ODS are typically delayed for two to six days
after swift elevations in the serum sodium level. The
symptoms, which are often irreversible or only partially
reversible, include dysarthria, dysphagia, tetraparesis, be-
havioral disturbances, lethargy, confusion, disorientation,
and coma [1]. ODS can also occur during other osmotic
challenges such as rapid correction of hypernatremia [2]
and the development of acute hypernatremia from nor-
mal sodium concentrations [3,4].
When CPM is associated with the rapid correction of
hyponatremia, plasma exchange (plasmapheresis) can be a
beneficial therapy. In fact, Bibl et al. reported that three
young female patients with CPM, which associated with
correction of hyponatremia, were successfully treated with
extensive therapeutic plasma exchange [5]. However, ours
is the first case report of CPM after rapid development of
hypernatremia from sodium bicarbonate therapy to be
successfully treated by plasma exchange.
Case presentation
A 40-year-old woman presented with general weakness,
nausea, vomiting, numbness, and weight loss of 8 kg over
the previous two months. The patient was 154 cm tall and
weighed 57 kg. Her blood pressure was 100/60 mmHg
and pulse was 110 beats/min. She was on no diuretics or
other medications. She did not have a medical history or
diarrhea upon presentation. On admission, she had weak-
ness in both limbs (Medical Research Council Grade 2),
but her deep-tendon reflexes were intact. Babinski’s sign
and ankle clonus were absent.
Upon initial laboratory analysis, her sodium was
142.8 mEq/L; potassium, 2.3 mEq/L; chloride, 125.5 mEq/
L; calcium, 7.7 mg/dL; phosphorus, 1.1 mg/dL; magne-
sium, 2.6 mg/dL; blood urea nitrogen, 17.7 mg/dL; cre-
atinine, 1.0 mg/dL; and albumin, 4.2 g/dL. Her spot urine
potassium was 16.9 mEq/L, and the transtubular potas-
sium gradient (TTKG) was 7%, suggesting renal loss.
Blood gas analysis revealed a pH of 7.194, PCO2 of
19.5 mmHg, PO2 of 67.8 mmHg, HCO3 of 7.6 mEq/L,
SpO2 of 90.2%, and a serum anion gap of 9.7, suggesting
normal anion gap metabolic acidosis. Urinalysis revealed a
pH of 6.5 and a urine anion gap of 6.1.
Due to the patient’s hypotension and altered mental
status, she was admitted to the intensive care unit. She
required mechanical ventilatory support with supple-
mental oxygen due to lethargy, somnolence, and respira-
tory failure (PCO2 45.3 mmHg). She was treated with
intravenous potassium chloride and an oral potassium
chloride tablet via nasogastric tube.In addition to ventilatory support, she also required
treatment for her severe acidemia with sodium bicarbon-
ate. Her desired bicarbonate level was 24 mEq, and her
bicarbonate deficit was calculated to be 365 mEq from the
following formula: bicarbonate deficit = (0.5 × lean body
weight) × (24- serum bicarbonate) [6]. Her lean body
weight was calculated to be 44.5 kg from the following
formula: lean body weight [kg] = 9270 × body weight [kg]/
6680 + (216 x BMI [kg/m2]). We treated her with an over-
dose of 480 mEq of intravenous sodium bicarbonate in 5%
dextrose and water solution because her mental status
and severe metabolic acidosis did not improve. The next
day, her potassium was corrected to normal levels
(4.2 mEq/L). However, we found acute hypernatremia
with her sodium levels rising from 142.8 mEq/L to
172.8 mEq/L. We began treating her with half-normal sa-
line and 5% dextrose in water, and her serum sodium level
gradually decreased from 172.8 mEq/L to 148.0 mEq/L
over the course of six days (Figure 1). As her hypernatre-
mia was corrected, she became more alert and her
weakness was greatly improved.
Six days after the development of hypernatremia, several
other symptoms became evident including dysarthria,
drooling, difficulty swallowing, and tetraparesis. Because
of these symptoms, we suspected ODS associated with
acute hypernatremia. Consistent with our clinical suspi-
cion, a brain MRI revealed symmetric, high-intensity
signal in the central pons with sparing of the peripheral
portion, suggesting CPM (Figure 2). Soon after this diag-
nostic confirmation of CPM, two consecutive therapeutic
plasma exchange sessions for two days were started with a
total of 4394 mL plasma exchanged with albumin 5%,
crystalloids, and fresh frozen plasma. The day following
the plasma exchange, she regained speech and became
oriented. Her neurological symptoms, which included
dysarthria, difficulty swallowing, and tetraparesis, were
markedly improved, but mild diplopia was present.
After the patient was stabilized, we were able to work
her up to explore the primary cause of her presenting
symptoms. We suspected distal renal tubular acidosis
(RTA) due to the normal anion gap metabolic acidosis, a
serum bicarbonate level < 10, hypokalemia, and urine pH
of 6.5 (> 5.5), and due to the presence of a calyceal stone
in her left kidney. We performed a sodium bicarbonate
(NaHCO3) loading test to confirm distal RTA [7]. In
NaHCO3 loading test, 8.4% NaHCO3 solution was infused
intravenously at a rate of 57 mEq/hour (1 mEq/kg/hour).
Urine and blood samples were taken at 1-hour intervals
and urine and blood PCO2 were measured using a blood
gas analyzer. When the urine pH was raised to 7.6, urine
PCO2, blood PCO2, urine HCO3, blood HCO3, urine
creatinine and serum creatinine were 44.5 mmHg,
34.8 mmHg, 40.1 mEq/L, 25.8 mEq/L, 64.5 mg/dL, and
0.7 mg/dL, respectively. The results of NaHCO3 loading
Figure 1 Sodium level changes.
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and the urine-to-blood carbon dioxide tension gradient
(U-B PCO2) of 9.7, suggesting distal RTA. In addition
to the distal RTA, we also found that she had Sjögren’s
syndrome after the results of Schirmer’s test and after
she screened positive for anti-Lo and anti-Ra, which
was confirmed by a salivary scan and lower lip biopsy.
She was discharged and treated at an outpatient clinic
with oral sodium bicarbonate and potassium chloride.
After one year of follow-up, her neurological symptoms
were improved, but mild diplopia remained.
Discussion
Hypernatremia is defined as a serum sodium concentra-
tion above 145 mEq/L, and it is most often caused by
water loss from the gastrointestinal tract due to vomiting
or diarrhea, water loss from the skin by sweating, or loss
in the urine due to diabetes insipidus, administration of
diuretics, recovery from renal failure, or glucosuria. Less
commonly, hypernatremia results from the administra-
tion of salt in excess of water, such as after intravenousFigure 2 MRI of the brain revealed symmetric, high-intensity signal in
central pontine myelinolysis (A, axial view and B, sagittal view).administration of hypertonic saline and salt tablets [8].
In addition, it may occur with the use of certain drugs,
such as lithium and valproate [9,10], and it has also been
shown to occur in patients treated with excess sodium
bicarbonate to correct metabolic acidosis [11]. In this
case, acute hypernatremia resulted from intravenous
sodium bicarbonate therapy for the treatment of severe
metabolic acidosis and altered mental status in a patient
with symptomatic distal RTA and Sjögren’s syndrome.
Osmotic disturbances like rapid correction of hypona-
tremia can be associated with demyelination of the pons,
causing CPM. The disruption of blood brain barrier
(BBB) occur secondary to osmotic stress and is thought
to be one of the leading factors in pathogenesis of CPM.
In fact, in a murine experiment, BBB disruption during
the first 24 hours of hyponatremia was associated with a
70% risk of demyelination [12]. CPM can occur in the
setting of several osmotic challenges. First, rapid and ex-
cessive correction of sodium in hyponatremia, usually an
increase in sodium concentration of more than 18 mg/
dL in the first 48 hours, can be associated with CPM.the pons with sparing of the peripheral portion, suggesting
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alcoholism, CPM can be associated with acute hyperna-
tremia and hyperglycemia after administration of lactu-
lose for the treatment of hepatic encephalopathy [13].
Third, CPM is associated with acute hypernatremia [3,4]
and the rapid correction of hypernatremia [2,4]. The
relationship between acute hypernatremia and CPM is
well characterized in animal experiments, showing acute
hypernatremia to result in brain myelinolysis and cellu-
lar necrosis [14]. Additionally, animal experiments
demonstrated that the osmotic gradient necessary to
induce brain myelinolysis is higher for normonatremic
than for hyponatremic rats [15]. In our case, an overdose
of intravenous sodium bicarbonate was associated with
not only acute hypernatremia, but also CPM.
Because there are no proven effective therapies for
CPM, its prevention is essential. Supportive therapy
should be provided to all patients who were functional
prior to the onset of CPM and should be continued for
at least six to eight weeks before drawing conclusions
about the severity of the deficits and their irreversibility
[16]. There have been some animal studies investigating
the benefits of re-inducing hyponatremia in the case of
rapid overcorrection of hyponatremia in order to avoid os-
motic demyelination. Gankam Kengne et al. demonstrated
that re-induction of hyponatremia by an intraperitoneal
administration of water 12 hours after rapid overcorrection
of hyponatremia effectively prevented the opening of the
BBB, reduced neurological manifestations, decreased
microglial activation, and resulted in a significant decrease
in mortality in rats [17]. The rat experiment by Soupart
et al. showed that after exposure to an excessive correction
of chronic hyponatremia, even when rats have developed
myelinolysis-related neurologic symptoms, hypotonic fluids
administration could improve survival and could prevent
the subsequent development of brain myelinolysis [18].
Although there are no well-studied therapies for CPM,
plasma exchange might be a beneficial therapy when CPM
is associated with rapid correction of hyponatremia. For
example, according to Bibl et al., three young female pa-
tients with CPM were successfully treated with extensive
therapeutic plasma exchange [5]. These three patients
were treated with plasma exchange for three to seven
weeks, and their neurological symptoms were improved
within two to twelve months. Because undefined myelin-
toxic compounds released by osmotic stress contribute to
the irreversible demyelinating process in CPM, thera-
peutic plasma exchange may exert its effect by reducing
these high-molecular weight myelin-toxic substances,
leading to clinical improvement [5]. This theory may
explain why plasma exchange was effective in our case of
CPM due to acute hypernatremia. Our patient’s neuro-
logical symptoms, which included dysarthria, difficulty
swallowing, and tetraparesis, were markedly improved theday after the two-session regimen of plasma exchange.
However, mild diplopia did remain after one year.
Our patient’s course supports the concept that intraven-
ous sodium bicarbonate therapy for the treatment of
metabolic acidosis can be associated with acute hyperna-
tremia and CPM. In the setting of acute hypernatremia,
CPM may be successfully treated with plasma exchange,
likely due to the rapid correction of the hyponatremia.
Conclusion
Our case indicates that serum sodium concentrations
should be carefully monitored in patients with distal RTA
who are receiving intravenous sodium bicarbonate therapy.
We should keep in mind that acute hypernatremia and
CPM can be associated with intravenous sodium bicarbon-
ate therapy, and CPM due to acute hypernatremia may be
effectively treated with plasma exchange.
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